Home / Street Sector / Recommended Momentum ‘How’ and ‘Why’: Repligen (NASDAQ:RGEN), Medical Properties Trust (NYSE:MPW), VEREIT (NYSE:VER)

Recommended Momentum ‘How’ and ‘Why’: Repligen (NASDAQ:RGEN), Medical Properties Trust (NYSE:MPW), VEREIT (NYSE:VER)

Shares of Repligen Corporation (NASDAQ:RGEN) [Trend Analysis] runs in leading trade, it plunging -8.52% to traded at $23.95. The firm has price volatility of 4.14% for a week and 4.52% for a month. Its beta stands at 1.40 times. Repligen Corporation (RGEN) announced that pricing of an underwritten public offering of $100 million aggregate principal amount of 2.125% Convertible Senior Notes due 2021. The Company has granted the underwriters a 30-day option to purchase up to an additional $15 million aggregate principal amount of Notes.

The offering is expected to close on or about May 24, 2016, subject to customary closing conditions. Jefferies is acting as the sole book-running manager, and Janney Montgomery Scott and Craig-Hallum Capital Group are acting as co-managers in the offering. Perella Weinberg Partners LP and J. Wood Capital Advisors LLC are serving as financial advisors to the Company in connection with the offering. Narrow down four to firm performance, its weekly performance was -8.97% and monthly performance was -12.14%. The stock price of RGEN is moving down from its 20 days moving average with -10.11% and isolated negatively from 50 days moving average with -9.96%.

Medical Properties Trust Inc. (NYSE:MPW) [Trend Analysis] luring active investment momentum, shares an increase 0.51% to $13.82. Medical Properties Trust, Inc. (MPW) announced that its BOD declared a regular quarterly cash dividend of $0.23 per share of common stock to be paid on July 14, 2016, to stockholders of record on June 16, 2016. “This additional payout to our shareholders continues our pattern of increasing our dividends as our long-term strategies create growing funds from operations,” said Edward K. Aldag, Jr., Chairman, President and CEO of Medical Properties Trust, Inc. “Since the beginning of 2014 our dividend has grown by 15%, and now represents one of the best payout ratios in our sector at between 75% and 80% of adjusted funds from operations, which is our target going forward.”

The total volume of 3.98 Million shares held in the session was surprisingly higher than its average volume of 1671.17 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at 118.10%, and looking further price to next year’s EPS is 4.04%. While take a short look on price to sales ratio, that was 6.86 and price to earning ratio of 20.32 attracting passive investors.

Several matter pinch shares of VEREIT, Inc. (NYSE:VER) [Trend Analysis], as shares plunging -1.48% to $9.34 with a share volume of 7.89 Million. VEREIT, Inc. (VER) released that that its operating partnership, VEREIT Operating Partnership, L.P. priced an upsized offering of $1.0 billion aggregate principal amount of senior notes, consisting of $400 million aggregate principal amount of 4.125% senior notes due 2021 and $600 million aggregate principal amount of 4.875% senior notes due 2026.

The offering size was increased to $1.0 billion from the previously announced $500 million aggregate principal amount. Interest on the Notes will be payable in cash and will accrue at a rate of 4.125% per annum for the 2021 Notes and 4.875% for the 2026 Notes. The Notes will be senior unsecured obligations of the Operating Partnership, guaranteed by VEREIT. The offering of Notes is expected to close on June 2, 2016, subject to customary closing conditions. The stock is going forward its 52-week low with 39.82% and moving down from its 52-week high price with -6.04%. The float short ratio was 1.94%, as compared to sentiment indicator; Short Ratio was 2.68.


About Devon Leftovich

Check Also

Short Call on Analysts Review: Avon Products Inc. (NYSE:AVP), Coach, Inc. (NYSE:COH)

Avon Products Inc. (NYSE:AVP) [Trend Analysis] try to make new thrust in street and making …

Leave a Reply

Your email address will not be published. Required fields are marked *